Inozyme Pharma, Inc. INZY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

33/100

0/6 Pass

SharesGrow Intrinsic Value

Inozyme Pharma, Inc. (INZY) has 20 known insider and institutional holders on record. The largest holder is Longitude Capital Partners III, LLC with 4,174,379 shares. Other notable holders include ENRIGHT PATRICK G and Pivotal bioVenture Partners Fund I U.G.P., Ltd.

Over the last 12 months, insiders have made 1 transactions in INZY stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

INZY Insider Ownership

Top Holder

Longitude Capital Partners III, LLC

4,174,379 shares

Buys (12 mo)

$0.00 value

Sells (12 mo)

$0.00 value

12-Month Transaction Activity

Buy 0%

Sell 0%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Longitude Capital Partners Iii, Llc	10 Percent Owner	4,174,379	2022-04-21	100%
2	Enright Patrick G	Director	4,174,379	2022-04-21	100%
3	Pivotal Bioventure Partners Fund I U.g.p., Ltd	Director	2,661,154	2022-04-20	64%
4	Novo Holdings A/s	10 Percent Owner	2,194,379	2021-02-01	53%
5	Florence Anthony A. Jr.	10 Percent Owner	2,000,533	2020-07-28	48%
6	Sonsini Peter W.	10 Percent Owner	2,000,533	2020-07-28	48%
7	Makower Joshua	10 Percent Owner	2,000,533	2020-07-28	48%
8	Baskett Forest	10 Percent Owner	2,000,533	2020-07-28	48%
9	Sandell Scott D	10 Percent Owner	2,000,533	2020-07-28	48%
10	Makhzoumi Mohamad	10 Percent Owner	2,000,533	2020-07-28	48%
11	Pivotal Bioventure Partners Fund I, L.p.	Director	1,571,741	2023-08-03	38%
12	Bjarke Henric Bjorn	SVP, COO	105,441	2022-12-19	3%
13	Wenkert Deborah	SVP, CMO	100,000	2021-02-04	2%
14	Harris Erik	Director	56,000	2024-10-07	1%
15	Treco Douglas A	CEO & Chairman	49,865	2025-04-03	1%
16	Jungles Steven J	SVP, CTO	42,000	2021-03-17	1%
17	Huertas Pedro	SVP, CMO	36,074	2021-01-14	1%
18	Subramanian Sanjay	SVP, CFO & Head of Bd	32,888	2025-04-02	1%
19	Mathers Edward T	Director	28,000	2024-06-20	1%
20	Hopfner Robert Lorne	Director	28,000	2024-06-20	1%